長崎大学病院は、長崎県長崎市坂本にある大学病院。医学部と歯学部の附属病院である長崎大学医学部・歯学部付属病院から改称。長崎県内にある唯一の大学病院である。2014年の患者数は、医科外来303,453名、歯科外来100,364名、医科入院263,869名、歯科入院7,958名である。

During the past decade, Nagasaki University Hospital conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 15 clinical trials were completed, i.e. on average, 34.1% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 13 clinical trials were completed. i.e. 68.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nagasaki University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Pfizer" with 5 trials sponsored, "Nagasaki University" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Kyowa Kirin Co., Ltd." with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nagasaki University Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "AbbVie GK." with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Chukyo Hospital" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Nagasaki University Hospital" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Rheumatoid Arthritis" (3 trials), "Acute Ischemic Stroke" (2 trials), "Adult T-cell Leukemia-Lymphoma" (2 trials) and "Anastomotic Leak" (2 trials). Many other conditions were trialed in "Nagasaki University Hospital" in a lesser frequency.

Most popular intervention types in "Nagasaki University Hospital" are "Drug" (40 trials), "Biological" (4 trials), "Procedure" (4 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Guselkumab" (3 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nagasaki University Hospital" are 50 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nagasaki University Hospital". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Nagasaki University Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Nagasaki University Hospital, 3 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".